从人胎肝cDNA文库中钧取得到SLC38A3全长cDNA序列.利用生物信息学方法对SLC38A3蛋白序列进行分析,根据亲水性、抗原性、柔韧性及表面性等指标选择一段多肽序列作为抗原用于抗体制备.将该片段克隆到pET-DsbA融合蛋白表达载体上,在异丙基硫代半乳糖苷(IPTG)诱导下产生SLC38A3抗原肽.纯化目的蛋白并制备兔抗SLC38A3蛋白的多克隆抗体.利用Western blot鉴定抗体特异性,并初步分析该蛋白在人肺癌细胞A549内的定位.结果显示,成功构建了SLC38A3片段的原核表达载体,在大肠杆菌中实现可溶性表达,制备了特异性较高的人SLC38A3蛋白多克隆抗体,并证实该蛋白表达于细胞质内.为进一步研究SLC38A3的生物学功能奠定了基础.
[1] 柳峰松, 李婷, 王晓菲, 唐婷, LIU Feng-song, LI Ting, WANG Xiao-fei, TANG Ting. 中国明对虾ALFFc基因的原核表达与抗血清制备 [J]. 河北大学学报（自然科学版） 2010.doi:10.3969/j.issn.1000-1565.2010.01.019
[2] 何庆华, 孔祥峰, 吴永宁, 印遇龙, HE Qing-hua, KONG Xiang-feng, WU Yong-ning, YIN Yu-long. 氨基酸转运载体研究进展 [J]. 氨基酸和生物资源 2007.doi:10.3969/j.issn.1006-8376.2007.02.014
[3] MCGIVAN J D, PASTOR-ANGLADA M. Regulatory and molecular aspects of mammalian amino acid hanauort [J]. Biochemical Journal 1994, 299(02).
[4] CHAUDHRY F A, REIMER R J, KRIZAJ D. Molecular analysis of system N suggests novel physiological roles in nitrogenmetabolism and synaptic transmission [J]. Cell 1999, 99(07).
[5] NAGAVEDI S, UMAPATHY, LI Weiguo. Expression and Function of Glutamine Transporters SN1 (SNAT3)and SN2 (SNAT5) in Retinal Müller Cells [J]. Investigative Ophthalmology & Visual Science 2005, 46.
[6] Yoshioka C, Yasuda S, Kimura. Expression and role of SNAT3 in the placenta. [J]. Placenta 2009, 12(12).
[7] KHOLODNYUK IRINA D, KOZIREVA SVETLANA. Down regulation of 3p genes, LTF, SLC38A3 and DRRI, upon growth of human chromosome 3-mouse fibrosarcoma hybrids in severe combined immunodeficiency mice [J]. Cancer 2006, 119.
[8] Ruderisch N, Virgintino D, Makrides V, Verrey F. Differential axial localization along the mouse brain vascular tree of luminal sodium-dependent glutamine transporters Snat1 and Snat3. [J]. Journal of Cerebral Blood Flow and Metabolism: Official Journal of the International Society of Cerebral Blood Flow and Metabolism 2011, 7(7).
[9] CHRISTENSE H N. Role of amino acid transport and counter-transport in nutrition and metabolism [J]. Physiological Reviews 1990, 70.
[10] Lin J, Raoof DA, Thomas DG, Greenson JK, Giordano TJ, Robinson GS, Bourner MJ, Bauer CT, Orringer MB, Beer DG. L-type amino acid transporter-1 overexpression and melphalan sensitivity in Barrett's adenocarcinoma. [J]. Neoplasia: an international journal for oncology research 2004, 1(1).
[11] Kim DK, Ahn SG, Park JC, Kanai Y, Endou H, Yoon JH. Expression of L-type amino acid transporter 1 (LAT1) and 4F2 heavy chain (4F2hc) in oral squamous cell carcinoma and its precusor lesions. [J]. Anticancer Research: International Journal of Cancer Research and Treatment 2004, 3A(3A).
[12] YOON J H, KIM I J, KIM H. Amino acid transport system L is differently expressed in human normal oral keratinocytea and human oral cancer cells [J]. Cancer Letters 2005, 222.
[13] Haase C, Bergmann R, Fuechtner F, Hoepping A, Pietzsch J. L-Type Amino Acid Transporters LAT1 and LAT4 in Cancer: Uptake of 3-O-Methyl-6- 18F-Fluoro-L-Dopa in Human Adenocarcinoma and Squamous Cell Carcinoma In Vitro and In Vivo. [J]. The Journal of Nuclear Medicine 2007, 12(12).
[14] CAMBELL W A, THOMPSON N L. Overexpression of LAT1/CD98 light chain is sufficient to increase system L-amino acid tranapor activity in mouse hepatocytes but not fibroblasta [J]. Journal of Biological Chemistry 2001, 276.
